PenderFund Capital Management »

Cardlytics shares owned by PenderFund Capital Management

Quarter-by-quarter ownership of Cardlytics shares owned by PenderFund Capital Management from 13F filings

Historical chart of PenderFund Capital Management investment in Cardlytics

Tip: Access up to 7 years of quarterly data

All positions including Cardlytics held by PenderFund Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cardlytics by PenderFund Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.5M 2.0M 1.25

More positions owned by PenderFund Capital Management

Esperion Therapeutics Inc Ne Note 4.000%11/1 (Principal)
First Majestic Silver Corp Note 0.375% 1/1 (Principal)
Bandwidth Note 0.500% 4/0 (Principal)
Ssr Mining In Note 2.500% 4/0 (Principal)
Sangoma Technologies Corp Com New (SANG)
Novavax Note 5.000%12/1 Added (Principal)
Burford Cap Ord Shs (BUR)
PAR Technology Corporation (PAR)
Western Asset Emerging Mrkts Dbt Fnd (EMD)
Nuveen Div. Advantage Muni. Fund (NAD)
Nuveen Municipal Credit Com Sh Ben Int (NZF)
Cable One Note 1.125% 3/1 (Principal)
Docebo (DCBO)
Aviat Networks Com New (AVNW)
Nuveen Insured Tax-Free Adv Munici (NEA)

View all positions for PenderFund Capital Management

Top funds holding Cardlytics

Oaktree Capital Management
Whitebox Advisors
Russell Investments
Penn Mutual Asset Management
Context Capital Management
Brown Trout Management
Morgan Stanley

View all funds holding Cardlytics